NTRK2 and metastatic neoplasm: Suppression of endogenous TrkB signaling by Trk inhibitors not only led to inhibited choriocarcinoma cell invasion but also decreased their metastasis to distant organs, accompanied by suppressed growth of metastatic tumors.